Home INDIA Covaxin safe for 2-18 age group: BB study

Covaxin safe for 2-18 age group: BB study

31
0

It conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in children and adolescents in the 2-18 years of age group between June- September 2021, Bharat Biotech said in a statement.

LEAVE A REPLY

Please enter your comment!
Please enter your name here